The 2.53 billion shares held by Greenland Group have been frozen. According to the legal litigation information of Tianyancha, recently, Guangxi Construction Engineering Group Co., Ltd. added a piece of information on the freezing of shares. The executor is Greenland Holding Group Co., Ltd., and the amount of frozen shares is about 2.53 billion RMB. The freezing period is from December 9, 2024 to December 8, 2027. The enforcement court is Wanzhou District People's Court in Chongqing.Li Ka-shing's H-share shareholding in China Postal Savings Bank decreased from 5.07% to 4.96%.The attack on the headquarters of the Ministry of Refugees and Repatriation in Afghanistan killed four people. An official from the Ministry of Interior of the Afghan Interim Government said on the 11th that the suicide attack at the headquarters of the Ministry of Refugees and Repatriation that day killed four people and seriously injured four others. Mufti Abdul Martin Carney, spokesman of the Interior Ministry of the Afghan interim government, issued a statement on the 11th, confirming that Khalil Rahman Haqqani, Acting Minister of Refugee and Repatriation Affairs, was killed in the attack. Haqqani is one of the leading figures of the Taliban in Afghanistan, and also the uncle of sirajuddin Haqqani, Acting Minister of the Interior of the Afghan Interim Government. (Xinhua News Agency)
By 2029, China will build about 10,000 superior specialties of traditional Chinese medicine. According to state administration of traditional chinese medicine, China will promote the construction of superior specialties of traditional Chinese medicine at different levels to further improve the clinical efficacy of traditional Chinese medicine. By 2029, the overall scale of superior specialties of traditional Chinese medicine will reach about 10,000. Recently, state administration of traditional chinese medicine issued opinions on accelerating the construction of superior specialties of traditional Chinese medicine, and put forward the requirements of strengthening the planning and layout of superior specialties of traditional Chinese medicine and promoting the construction of superior clusters of traditional Chinese medicine. (CCTV News)Meili Technology: Meili, a wholly-owned subsidiary, plans to purchase assets related to MSSC AHLE GmbH for 8.1 million euros. Meili, a wholly-owned subsidiary of Meili Technology, signed an Asset Purchase Agreement with MSSC AHLE GmbH(AHLE Company) on December 10, 2024 to purchase assets related to AHLE Company's business at a transaction consideration of 8.1 million euros, including factory buildings, production equipment, inventory, intangible assets, contractual rights, etc. AHLE Company was established in 1904, and its main business is spring research and development, manufacturing, sales and trade, etc. Its main products include automobile suspension springs, brake chamber springs and recovery springs, and its customers include Volkswagen, ZF and other OEMs and first-class suppliers. Due to operational difficulties, the bankruptcy court in Cologne, Germany, initiated bankruptcy proceedings on the property of AHLE Company on October 1, 2024. Germany Meili purchased these assets by auction, and the transaction price was based on the Financial Due Diligence Report and the Legal Due Diligence Report issued by a third-party intermediary agency, taking into account the market position, channels, customers and future market opportunities of the subject matter of the transaction.The Nikkei 225 index just broke through the 39,900.00 mark, and the latest report was 39,899.07, up 1.34% in the day.
Weilai Li Bin: R&D investment is in basic research. Weilai's R&D expenses for Le Dao are far less than Xiaomi's R&D expenses for Xiaomi Automobile. (Sina Technology)The monkeypox vaccine with independent intellectual property rights in China was approved for clinical use. On December 10th, the monkeypox vaccine jointly developed by China Bio-Beijing Institute of Biological Products and China Center for Disease Control and Prevention received the approval notice of drug clinical trial issued by National Medical Products Administration, and it was registered and classified as Class 1.2 innovative vaccine. The vaccine is an innovative vaccine independently developed by scientists in China with completely independent intellectual property rights, which is expected to play an important role in the prevention and control of diseases caused by monkeypox virus in China. (China Biology)Schlegel, Governor of the Swiss National Bank: Since the last interest rate decision, the inflation rate has been lower than expected. The development of the Swiss franc is still an important factor.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide